Related Experiment Video
Updated: Sep 26, 2026

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Meta-analysis of corticosteroid treatment in acute myocardial infarction
Gregory R Giugliano1, Robert P Giugliano, C Michael Gibson
1Division of Clinical Biometrics, Brigham & Women's Hospital, Boston, Massachusetts 02115, USA. ggiugliano@partners.org
Insights
Corticosteroids may reduce mortality in acute myocardial infarction (AMI) patients. This review found no evidence of harm, suggesting a potential mortality benefit for this anti-inflammatory treatment in AMI.
Area of Science:
- Cardiology
- Pharmacology
- Inflammation Research
Background:
- Acute and chronic inflammation are key in atherosclerosis.
- Corticosteroids are standard anti-inflammatories but raise concerns about impaired healing in myocardial infarction (MI).
Purpose of the Study:
- To evaluate the safety and efficacy of corticosteroids in treating acute myocardial infarction (AMI).
Main Methods:
- A meta-analysis of controlled trials was conducted using MEDLINE and PreMEDLINE databases (1966-2002).
- Included 16 studies with 3,793 patients; meta-analysis focused on 11 trials (2,646 patients) for mortality.
- Sensitivity analyses and publication bias tests were performed.
Main Results:
- Most studies were small with conflicting surrogate outcomes (e.g., infarct size).
- No clear link to myocardial rupture was found.
- Meta-analysis showed a 26% decrease in mortality with corticosteroids (OR 0.74, P=0.015).
Conclusions:
- Corticosteroid use in acute myocardial infarction demonstrated no observed harm.
- A potential mortality benefit exists, warranting further investigation.
Abstract:
Acute and chronic inflammation play a central role in the pathophysiology of atherosclerosis. Corticosteroids are the gold standard anti-inflammatory agent and may have a role in treating acute myocardial infarction. However, concern exists regarding the potential for impaired wound healing and wall thinning. The MEDLINE and PreMEDLINE databases were searched for articles from 1966 through May 2002. A total of 186 articles and 16 English-language publications were identified. A meta-analysis of mortality in controlled trials was performed. Sensitivity analyses and 2 tests for publication bias were used to test the robustness of the results. Sixteen studies involving 3,793 patients were reviewed. Most studies were small (<100 patients) and revealed conflicting efficacy using surrogate outcome measures, such as infarct size. No clear association with myocardial rupture was observed. Meta-analysis of 11 controlled trials (2,646 patients) revealed a 26% decrease in mortality with corticosteroids (odds ratio 0.74, 95% confidence interval [CI] 0.59 to 0.94; p = 0.015). Sensitivity analyses limited to large studies and randomized controlled trials revealed odds ratios of 0.76 (95% CI 0.53 to 1.09) and 0.95 (95% CI 0.72 to 1.26), respectively. Two tests revealed no evidence for publication bias. Thus, the review of available clinical studies demonstrated no harm and a possible mortality benefit of corticosteroids in acute myocardial infarction.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Myocarditis III: Medical Management
Acute Coronary Syndrome III: Diagnostic Studies
Myocarditis IV: Nursing Management
Myocarditis II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome I: Introduction
